top of page
Research News
Brain Changes to an Initial rTMS Might Be a Predictor of Treatment Response in Major Depression
Writter: Ruiyang Ge (PhD, University of British Columbia) Major depressive disorder (MDD) remains amongst the leading causes of disability in Canada and worldwide, and the COVID-19 pandemic has exacerbated this situation. The high prevalence and disability associated with MDD make research aimed at understanding its pathophysiology and developing effective treatments an important priority for public health. Over the last decade, repetitive transcranial magnetic stimulation (r
bottom of page